Molecular Formula | C32H22O10 |
Molar Mass | 566.51 |
Density | 1.506±0.06 g/cm3(Predicted) |
Melting Point | 297 °C(Solv: acetone (67-64-1)) |
Boling Point | 863.7±65.0 °C(Predicted) |
Flash Point | 287.1°C |
Solubility | DMSO : ≥ 83.3 mg/mL (147.04 mM) |
Vapor Presure | 2.28E-31mmHg at 25°C |
Appearance | White crystalline powder |
pKa | 6.18±0.40(Predicted) |
Storage Condition | 2-8℃ |
Refractive Index | 1.714 |
MDL | MFCD09970948 |
Physical and Chemical Properties | Soluble in methanol, ethanol, DMSO and other organic solvents, from Ginkgo biloba. |
Reference Show more | 1. Zhang, Lei, Jiangang Liu, and Tao Geng. "Ginkgetin aglycone attenuates the apoptosis and inflammation response through nuclear factor‐kB signaling pathway in ischemic‐reperfusion injury." Journal of cellular biochemistry 120.5 (2019): 8078-8085.https://doi 2. Xu, Bing, et al. "Ginkgetin aglycone attenuates neuroinflammation and neuronal injury in the rats with ischemic stroke by modulating STAT3/JAK2/SIRT1." Folia Neuropathol 57.1 (2019): 16-23.https://doi.org/10.5114/fn.2019.83827 3. [IF=5.396] Zhu Tao et al."Evaluation of the anti-inflammatory properties of the active constituents in Ginkgo biloba for the treatment of pulmonary diseases."Food Funct. 2019 Apr;10(4):2209-2220 4. [IF=4.411] Li Yang et al."Seasonal Dynamics of Metabolites in Needles of Taxus wallichiana var. mairei."Molecules. 2016 Oct;21(10):1403 5. [IF=7.514] Jie Meng et al."Conduction of a chemical structure-guided metabolic phenotype analysis method targeting phenylpropane pathway via LC-MS: Ginkgo biloba and soybean as examples."FOOD CHEMISTRY. 2022 Oct;390:133155 |
biological activity | Ginkgetin is a diflavone isolated from ginkgo biloba. Ginkgetin has anti-tumor, anti-inflammatory, neuroprotective and antifungal effects. Ginkgetin is also a potent inhibitor of Wnt signaling with an IC50 value of 5.92 μM. |
Cell Line: | Daoy and D283 cell lines Osteosarcoma cells Daoy cells Daoy and D283 cell lines |
Concentration: | 2.5, 5, 10, 20 μM 20, 30, 40 μM 2.5, 5, 10, 20 μM 10, 20 μM |
Incubation Time: | 48 hours 24 hours 24 hours 3, 6, 12, 24 hours |
Result: | Inhibited the cell growth, with IC 50 s of 14.65 and 15.81 μM for Daoy and D283 cells, respectively. Markedly induced the apoptosis of osteosarcoma cells in a concentration-dependent manner. Increased G 2 /M phase, compared with that of control, indicating a G 2 /M cell phase arrest. Attenuated the expression of Wnt target genes, Axin2, cyclin D1 and survivin at 20 μM for 24 h in Daoy cells. Unaffected the level of total β-catenin and diminished the level of β-catenin phosphorylation in a time- and concentration-dependent manner. Reduced the neurological deficit score. Suppressed the expression of NF-κB, TLR4 and IκBαin ischemic penumbra cortex, and inhibited the degradation of IκBα. Decreased the expressions of ICAM-1, COX-2, and iNOS. Downregulated downstream inflammatory factor PGE2 and TNF-α expression. Decreased IL-1β, IL-6, IL-8, and IL-10 protein expression. |
Animal Model: | Male Sprague-Dawley rats (200-220 g) |
Dosage: | 25, 50, 100 mg/kg |
Administration: | I.p. 2 hours after the onset of ischemia |
use | ginkgo biloba has the effects of regulating blood lipid, lowering cholesterol and treating angina pectoris. used for content determination/identification/pharmacological experiment, etc. |